Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Helicobacter Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients.

NCT02691637 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT02691637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02691637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Helicobacter Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients.
Lead sponsor
Seoul National University Bundang Hospital
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
December 31, 2022
Enrollment
1,450 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, helicobacter pylori infection, intestinal metaplasia